The Global Burden of Disease, 1996. ,
URL : https://hal.archives-ouvertes.fr/hal-00921564
Comorbidity of Mental Disorders With Alcohol and Other Drug Abuse, JAMA, vol.264, issue.19, pp.2511-2518, 1990. ,
DOI : 10.1001/jama.1990.03450190043026
Lifetime Co-occurrence of DSM-III-R Alcohol Abuse and Dependence With Other Psychiatric Disorders in the National Comorbidity Survey, Archives of General Psychiatry, vol.54, issue.4, pp.54-313, 1997. ,
DOI : 10.1001/archpsyc.1997.01830160031005
DSM-III-R and Proposed DSM-IV Alcohol Abuse and Dependence, United States 1988: A Nosological Comparison, Alcoholism: Clinical and Experimental Research, vol.6, issue.6, pp.1068-1075, 1992. ,
DOI : 10.1111/j.1530-0277.1992.tb00701.x
DSM-III-R alcohol abuse and dependence and psychiatric comorbidity in Ontario: results from the Mental Health Supplement to the Ontario Health Survey, Drug and Alcohol Dependence, vol.39, issue.2, pp.111-128, 1995. ,
DOI : 10.1016/0376-8716(95)01150-W
The 12-month prevalence of substance use and ICD-10 substance use disorders in Australian adults: findings from the National Survey of Mental Health and Well-Being, Addiction, vol.94, issue.10, pp.1541-1550, 1994. ,
DOI : 10.1046/j.1360-0443.1999.9410154110.x
Drogues et adolescence: usages de drogues et contexts d'usage entre 17 et 19 ans, évolution récentes, OFDT, p.164, 2002. ,
Comorbidity between DSM-IV alcohol and specific drug use disorders in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions, Drug and Alcohol Dependence, vol.80, issue.1, pp.105-121, 2005. ,
DOI : 10.1016/j.drugalcdep.2005.03.009
Facteurs génétiques de l'alcoolisme, J Adès, M ,
Alcoolisme et Psychiatrie, Collection Médecine et Psychothérapie, pp.25-40, 1997. ,
Genetic susceptibility to substance dependence, Molecular Psychiatry, vol.10, issue.4, pp.336-380, 2005. ,
DOI : 10.1038/sj.mp.4001622
Hallucinogen, opiate, sedative and stimulant use and abuse in a population-based sample of female twins, Acta Psychiatrica Scandinavica, vol.49, issue.5, pp.368-76, 1999. ,
DOI : 10.1111/j.1600-0447.1999.tb07243.x
Co-occurrence of abuse of different drugs in men: the role of drugspecific and shared vulnerabilities, Arch Gen Psychiatry, issue.11, pp.55-967, 1998. ,
The genetics of pathological gambling, Seminars in Clinical Neuropsychiatry, vol.6, issue.3, pp.195-204, 2001. ,
DOI : 10.1053/scnp.2001.22931
Common Genetic Vulnerability for Pathological Gambling and Alcohol Dependence in Men, Archives of General Psychiatry, vol.57, issue.7, pp.666-73, 2000. ,
DOI : 10.1001/archpsyc.57.7.666
A multivariate genetic analysis of the use of tobacco, alcohol, and caffeine in a population based sample of male and female twins, Drug and Alcohol Dependence, vol.57, issue.1, pp.57-69, 1999. ,
DOI : 10.1016/S0376-8716(99)00053-8
Common Genetic Vulnerability for Nicotine and Alcohol Dependence in Men, Archives of General Psychiatry, vol.56, issue.7, pp.56-655, 1999. ,
DOI : 10.1001/archpsyc.56.7.655
Genetic Heterogeneity and the Classification of Alcoholism, Advances in Alcohol & Substance Abuse, vol.7, issue.3-4, pp.3-4, 1988. ,
DOI : 10.1300/J251v07n03_02
Gene???environment interactions in human diseases, Nature Reviews Genetics, vol.162, issue.4, pp.287-298, 2005. ,
DOI : 10.1093/hmg/ddg318
An Adoption Study of Genetic and Environmental Factors in Drug Abuse, Archives of General Psychiatry, vol.43, issue.12, pp.1131-1137, 1986. ,
DOI : 10.1001/archpsyc.1986.01800120017004
Tobacco Consumption in Swedish Twins Reared Apart and Reared Together, Archives of General Psychiatry, vol.57, issue.9, pp.886-92, 2000. ,
DOI : 10.1001/archpsyc.57.9.886
Interaction between serotonin transporter gene variation and rearing condition in alcohol preference and consumption in female primates, Arch Gen Psychiatry, pp.1146-52, 2004. ,
Serotonin transporter gene polymorphisms, alcoholism, and suicidal behavior, Biological Psychiatry, vol.48, issue.4, pp.259-264, 2000. ,
DOI : 10.1016/S0006-3223(00)00840-4
Polymorphismes g??niques de marqueurs s??rotoninergiques et alcoolod??pendance, m??decine/sciences, vol.20, issue.12, pp.1132-1138, 2004. ,
DOI : 10.1051/medsci/200420121132
EhrichEfficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial, JAMA, pp.293-1617, 2005. ,
Pharmacotherapy of Alcohol Dependence, CNS Drugs, vol.340, issue.3, pp.485-504, 2004. ,
DOI : 10.2165/00023210-200418080-00002
URL : https://hal.archives-ouvertes.fr/hal-01276028
A Functional Polymorphism of the ??-Opioid Receptor Gene is Associated with Naltrexone Response in Alcohol-Dependent Patients, Neuropsychopharmacology, vol.28, issue.8, pp.1546-1552, 2003. ,
DOI : 10.1038/sj.npp.1300219
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter, Nature, vol.379, issue.6566, pp.379-606, 1996. ,
DOI : 10.1038/379606a0
Allelic association of a dopamine transporter gene polymorphism in alcohol dependence with withdrawal seizures or delirium, Biological Psychiatry, vol.41, issue.3, pp.41-299, 1997. ,
DOI : 10.1016/S0006-3223(96)00044-3
The A9 allele of the DAT gene is associated with delirium tremens and alcohol-withdrawal seizure, Biol Psychiatry, pp.53-85, 2003. ,
Modification of alcohol withdrawal by the A9 allele of the dopamine transporter gene, Am J Psychiatry, pp.155-474, 1998. ,
Evidence for the importance of the human dopamine transporter gene for withdrawal symptomatology of alcoholics in a German population, Neuroscience Letters, vol.333, issue.1, pp.333-378, 2002. ,
DOI : 10.1016/S0304-3940(02)00985-0
The A9 allele of the dopamine transporter gene increases the risk of visual hallucinations during alcohol withdrawal in alcohol-dependent women, Neuroscience Letters, vol.362, pp.91-94, 2004. ,
Epidemiology of drug dependance, in :Textbook of Psychiatric Epidemiology, Wyley-Liss, pp.361-406, 1995. ,
The Electroencephalogram After Alcohol Administration in High-Risk Men and the Development of Alcohol Use Disorders 10 Years Later, Archives of General Psychiatry, vol.53, issue.3, pp.258-263, 1996. ,
DOI : 10.1001/archpsyc.1996.01830030080012
Risk increase (adjusted odds ratio with 95% confidence interval) for alcohol abuse or dependence of patients with drug abuse or dependence (controlling the role of sociodemographic factors, personality disorder, 12-month independent mood disorder and independent anxiety disorder) ,